Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

501 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MRI in-bore biopsy following MRI/US fusion-guided biopsy in patients with persistent suspicion of clinically significant prostate cancer.
Quentin M, Boschheidgen M, Radtke JP, Spohn F, Ullrich T, Drewes L, Valentin B, Lakes J, Al-Monajjed, Arsov C, Esposito I, Albers P, Antoch G, Schimmöller L. Quentin M, et al. Among authors: esposito i. Eur J Radiol. 2024 Jun;175:111436. doi: 10.1016/j.ejrad.2024.111436. Epub 2024 Mar 21. Eur J Radiol. 2024. PMID: 38522396 Free article.
Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy.
Klingebiel M, Arsov C, Ullrich T, Quentin M, Al-Monajjed R, Mally D, Sawicki LM, Hiester A, Esposito I, Albers P, Antoch G, Schimmöller L. Klingebiel M, et al. Among authors: esposito i. Data Brief. 2022 Oct 19;45:108683. doi: 10.1016/j.dib.2022.108683. eCollection 2022 Dec. Data Brief. 2022. PMID: 36426072 Free PMC article.
Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS Study.
Valentin B, Arsov C, Ullrich T, Al-Monajjed R, Boschheidgen M, Hadaschik BA, Giganti F, Giessing M, Lopez-Cotarelo C, Esposito I, Antoch G, Albers P, Radtke JP, Schimmöller L. Valentin B, et al. Among authors: esposito i. Eur Urol Open Sci. 2023 Dec 19;59:30-38. doi: 10.1016/j.euros.2023.10.005. eCollection 2024 Jan. Eur Urol Open Sci. 2023. PMID: 38298772 Free PMC article.
Prognostic markers for the clinical course in the blood of patients with SARS-CoV-2 infection.
Fischer JC, Balz V, Jazmati D, Bölke E, Freise NF, Keitel V, Feldt T, Jensen BO, Bode J, Lüdde T, Häussinger D, Adams O, Schneider EM, Enczmann J, Rox JM, Hermsen D, Schulze-Bosse K, Kindgen-Milles D, Knoefel WT, van Griensven M, Haussmann J, Tamaskovics B, Plettenberg C, Scheckenbach K, Corradini S, Pedoto A, Maas K, Schmidt L, Grebe O, Esposito I, Ehrhardt A, Peiper M, Buhren BA, Calles C, Stöhr A, Gerber PA, Lichtenberg A, Schelzig H, Flaig Y, Rezazadeh A, Budach W, Matuschek C. Fischer JC, et al. Among authors: esposito i. Eur J Med Res. 2022 Nov 21;27(1):255. doi: 10.1186/s40001-022-00864-z. Eur J Med Res. 2022. PMID: 36411478 Free PMC article.
BRAFV600E and BRAF-WT Specific Antitumor Immunity in Papillary Thyroid Cancer.
Ehlers M, Schmidt M, Mattes-Gyorgy K, Antke C, Enczmann J, Schlensog M, Japp A, Haase M, Allelein S, Dringenberg T, Giesel F, Esposito I, Schott M. Ehlers M, et al. Among authors: esposito i. Horm Metab Res. 2022 Dec;54(12):852-858. doi: 10.1055/a-1971-7019. Epub 2022 Nov 25. Horm Metab Res. 2022. PMID: 36427494 Free article.
Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis.
Stoecklein NH, Fluegen G, Guglielmi R, Neves RPL, Hackert T, Birgin E, Cieslik SA, Sudarsanam M, Driemel C, van Dalum G, Franken A, Niederacher D, Neubauer H, Fehm T, Rox JM, Böhme P, Häberle L, Göring W, Esposito I, Topp SA, Coumans FAW, Weitz J, Knoefel WT, Fischer JC, Bork U, Rahbari NN. Stoecklein NH, et al. Among authors: esposito i. Mol Cancer. 2023 Nov 13;22(1):181. doi: 10.1186/s12943-023-01880-1. Mol Cancer. 2023. PMID: 37957606 Free PMC article.
Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
Mazur PK, Herner A, Mello SS, Wirth M, Hausmann S, Sánchez-Rivera FJ, Lofgren SM, Kuschma T, Hahn SA, Vangala D, Trajkovic-Arsic M, Gupta A, Heid I, Noël PB, Braren R, Erkan M, Kleeff J, Sipos B, Sayles LC, Heikenwalder M, Heßmann E, Ellenrieder V, Esposito I, Jacks T, Bradner JE, Khatri P, Sweet-Cordero EA, Attardi LD, Schmid RM, Schneider G, Sage J, Siveke JT. Mazur PK, et al. Among authors: esposito i. Nat Med. 2024 May 30. doi: 10.1038/s41591-024-03054-y. Online ahead of print. Nat Med. 2024. PMID: 38816611 No abstract available.
501 results